AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Mpride V 1/0.3 Tablet SR

Prescription Icon
Prescription Required

Marketer

Ajanta Pharma Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)

Overview Mpride V 1/0.3 Tablet SR

DiaBeta Duo 1/0.3 SR tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by regulating blood glucose. Administer DiaBeta Duo 1/0.3 SR with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may adjust based on your blood sugar response. Continue this medication even with controlled blood sugar; abrupt cessation, without physician consultation, risks elevated glucose levels, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, it's one component of a comprehensive treatment plan encompassing a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is the most frequent adverse effect. Learn to recognize its symptoms – sweating, dizziness, headache, tremors – and appropriate countermeasures. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain may occur. Avoid this medication if you have type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any prior heart conditions before commencing treatment; it may be contraindicated. Pregnant or lactating individuals require physician consultation prior to use. Regular blood glucose monitoring is essential, along with potential blood tests for blood cell counts and liver function.

Primary Ingredients of Mpride V 1/0.3 Tablet SR

No text was provided. Please provide the text you wish me to rephrase.

Uses of Mpride V 1/0.3 Tablet SR

Managing type 2 diabetes

Major Benefits of Mpride V 1/0.3 Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Mpride V 1/0.3 Tablet SR on an empty stomach.

Common Side effects of Mpride V 1/0.3 Tablet SR:

  • Nausea
  • Diarrhea
  • Abdominal pain
  • Hypoglycemia (low blood glucose level)
  • Loss of appetite

How to use Mpride V 1/0.3 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Mpride V 1/0.3 Tablet SR on an empty stomach.

How Mpride V 1/0.3 Tablet SR works:

Mpride V 1/0.3 Extended-Release Tablet contains a triple combination of anti-diabetic agents.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Mpride V 1/0.3 Tablet SR and alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Mpride V 1/0.3 Tablet SR during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice before using this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The extended-release Mpride V 1/0.3mg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Mpride V 1/0.3 Tablet SR, as its use may be unsafe. Medical advice is recommended. This medication is especially not advised for those with severely impaired kidney function.

LiverLiverCAUTION

Individuals with liver impairment should exercise caution when using Mpride V 1/0.3 Tablet SR. Dosage modifications may be necessary. Physician consultation is advised. A low initial dose of Mpride V 1/0.3 Tablet SR is typically prescribed for patients with mild to moderate liver disease; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Mpride V 1/0.3 Tablet SR :

Should you forget to take a Mpride V 1/0.3 Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Mpride V 1/0.3 Tablet SR

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Mpride V 1/0.3 Tablet SR

Mpride V 1/0.3 Tablet SR combines glimepiride, metformin, and voglibose to manage type 2 diabetes mellitus (DM) in adults. This triple therapy, used alongside diet and exercise, improves blood glucose control. Glimepiride stimulates insulin release from the pancreas; metformin reduces liver glucose production and enhances insulin sensitivity; and voglibose, an alpha-glucosidase inhibitor, lowers post-meal glucose levels. This combination is unsuitable for type 1 DM.
Mpride V 1/0.3 Tablet SR may cause common side effects including low blood sugar (hypoglycemia), nausea, diarrhea, altered taste perception, gas, stomach pain, headache, skin rash, and respiratory infections.
Mpride V 1/0.3 Tablet SR is contraindicated in patients allergic to its components or excipients, those with moderate to severe kidney disease, and those with inflammatory bowel disease, colonic ulcerations, or underlying metabolic acidosis (including diabetic ketoacidosis).
Combining Mpride V 1/0.3 Tablet SR and alcohol is unsafe. This combination can dangerously lower blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Mpride V 1/0.3 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with skipped meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Store this medication in its original, tightly sealed container, following the storage instructions provided. Discard any unused medication safely and ensure it remains inaccessible to children, pets, and others.
Mpride V 1/0.3 Tablet SR
175
MRP 203
13% off